Your browser is no longer supported. Please, upgrade your browser.
PCRX Pacira BioSciences, Inc. monthly Stock Chart
PCRX [NASD]
Pacira BioSciences, Inc.
Index- P/E22.46 EPS (ttm)2.84 Insider Own1.30% Shs Outstand42.93M Perf Week-2.94%
Market Cap2.75B Forward P/E17.84 EPS next Y3.58 Insider Trans-54.03% Shs Float40.28M Perf Month22.53%
Income126.10M PEG0.75 EPS next Q0.80 Inst Own- Short Float15.15% Perf Quarter4.93%
Sales421.10M P/S6.53 EPS this Y26.90% Inst Trans-0.19% Short Ratio13.94 Perf Half Y43.11%
Book/sh13.62 P/B4.68 EPS next Y68.60% ROA13.50% Target Price66.38 Perf Year39.76%
Cash/sh12.35 P/C5.17 EPS next 5Y30.00% ROE29.60% 52W Range27.46 - 68.08 Perf YTD40.84%
Dividend- P/FCF96.82 EPS past 5Y7.30% ROI1.50% 52W High-6.28% Beta1.30
Dividend %- Quick Ratio6.80 Sales past 5Y16.30% Gross Margin72.90% 52W Low132.34% ATR2.93
Employees606 Current Ratio7.60 Sales Q/Q12.20% Oper. Margin5.00% RSI (14)61.12 Volatility4.33% 5.53%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin30.00% Rel Volume0.32 Prev Close63.36
ShortableYes LT Debt/Eq0.78 EarningsOct 29 BMO Payout0.00% Avg Volume437.86K Price63.80
Recom2.10 SMA207.62% SMA509.61% SMA20028.21% Volume140,184 Change0.69%
Sep-21-20Upgrade Northland Capital Market Perform → Outperform $58 → $67
Jul-06-20Reiterated Needham Buy $52 → $64
May-27-20Initiated Guggenheim Neutral
Apr-07-20Initiated Northland Capital Outperform $50
Mar-20-20Upgrade SVB Leerink Mkt Perform → Outperform $44
Feb-24-20Reiterated H.C. Wainwright Buy $60 → $63
Jan-24-20Initiated SunTrust Buy
Jan-23-20Initiated SunTrust Buy
Nov-06-19Initiated BTIG Research Buy $56
Jun-11-19Initiated Barclays Overweight $52
May-06-19Upgrade Mizuho Underperform → Neutral $29 → $38
May-02-19Upgrade Stifel Sell → Hold $45
Feb-01-19Downgrade Mizuho Neutral → Underperform
Aug-06-18Downgrade BofA/Merrill Buy → Neutral
Apr-09-18Reiterated H.C. Wainwright Buy $45 → $48
Mar-21-18Reiterated Mizuho Neutral $44 → $31
Feb-16-18Downgrade Needham Buy → Hold
Jan-19-18Initiated Seaport Global Securities Buy $50
Jan-04-18Reiterated Canaccord Genuity Buy $42 → $46
Jan-03-18Initiated Leerink Partners Mkt Perform $46
Nov-24-20 07:30AM  
Nov-19-20 10:08AM  
Nov-18-20 07:30AM  
Nov-16-20 01:48PM  
Nov-13-20 10:40AM  
Nov-11-20 01:27PM  
08:00AM  
Nov-10-20 07:30AM  
Nov-09-20 12:42PM  
Oct-30-20 12:57PM  
03:01AM  
Oct-29-20 09:15AM  
08:00AM  
06:30AM  
Oct-22-20 12:33PM  
Oct-21-20 07:30AM  
06:25AM  
Oct-20-20 07:30AM  
Oct-19-20 11:30AM  
Oct-07-20 08:00AM  
Sep-21-20 11:56AM  
Sep-18-20 08:07AM  
Sep-16-20 02:55PM  
Sep-15-20 07:30AM  
Sep-11-20 07:30AM  
Sep-09-20 08:00AM  
Sep-05-20 11:31AM  
Aug-06-20 08:00AM  
Aug-05-20 04:05PM  
07:30AM  
Aug-04-20 07:30AM  
Jul-30-20 07:30AM  
Jul-28-20 05:03PM  
Jul-12-20 12:43PM  
Jul-07-20 07:51PM  
Jul-06-20 04:02PM  
04:01PM  
Jul-02-20 07:30AM  
Jun-29-20 09:00AM  
Jun-16-20 07:30AM  
Jun-10-20 04:36PM  
May-27-20 07:30AM  
May-13-20 07:30AM  
May-07-20 08:00AM  
May-04-20 07:30AM  
Apr-30-20 07:30AM  
Apr-23-20 08:59AM  
Apr-07-20 05:00PM  
Apr-06-20 08:00AM  
Mar-21-20 11:30AM  
Mar-17-20 09:53AM  
Mar-13-20 12:45PM  
11:40AM  
Mar-10-20 10:24AM  
Mar-09-20 07:30AM  
Mar-05-20 07:44AM  
Mar-04-20 09:22AM  
Feb-27-20 12:32AM  
Feb-26-20 12:45PM  
11:40AM  
Feb-23-20 09:46AM  
Feb-21-20 10:22AM  
09:45AM  
Feb-20-20 08:00AM  
Feb-19-20 09:21AM  
Feb-13-20 07:30AM  
Feb-12-20 09:45AM  
Feb-11-20 06:39AM  
Feb-07-20 06:52AM  
Feb-06-20 08:36AM  
08:10AM  
Feb-05-20 08:37AM  
Feb-03-20 08:53AM  
Jan-22-20 08:53AM  
Jan-21-20 09:06AM  
07:30AM  
Jan-13-20 11:40AM  
Jan-09-20 07:30AM  
Jan-08-20 11:16AM  
07:30AM  
Jan-07-20 02:08PM  
10:21AM  
07:30AM  
Dec-27-19 11:40AM  
Dec-26-19 11:52AM  
Dec-18-19 09:23AM  
Dec-17-19 07:30AM  
Dec-16-19 03:44PM  
Dec-10-19 11:40AM  
Dec-07-19 11:31AM  
Dec-04-19 08:03PM  
Nov-26-19 07:30AM  
Nov-13-19 11:00AM  
07:30AM  
05:51AM  
Nov-08-19 11:31AM  
Nov-07-19 09:25AM  
08:00AM  
Oct-31-19 10:33AM  
Oct-30-19 09:15AM  
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a non-opioid medication administered at the time of surgery to control pain while reducing opioid requirements; and iovera system, a handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company has collaboration with Aetna. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brege LauraDirectorNov 16Option Exercise13.9812,000167,76019,921Nov 17 05:39 PM
Brege LauraDirectorNov 16Sale65.9512,000791,4007,921Nov 17 05:39 PM
REINHARDT MAXPresidentNov 13Option Exercise42.5425,0001,063,50039,000Nov 17 05:28 PM
Riker Lauren BullaroVice President, FinanceNov 13Option Exercise10.813,00032,43016,181Nov 17 05:37 PM
Riker Lauren BullaroVice President, FinanceNov 13Sale63.813,000191,43013,181Nov 17 05:37 PM
WINSTON ROYChief Clinical OfficerNov 13Sale62.005,000310,00034,785Nov 17 05:30 PM
REINHARDT MAXPresidentNov 13Sale63.3825,0001,584,39014,000Nov 17 05:28 PM
STACK DAVID MCEO and ChairmanOct 16Option Exercise10.8130,000324,300203,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 16Sale55.5630,0001,666,800173,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 15Option Exercise10.8130,000324,300203,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 15Sale55.0030,0001,650,000173,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 14Option Exercise10.8130,000324,300203,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 14Sale55.5330,0001,665,900173,377Oct 16 04:26 PM
PACE GARY WDirectorSep 25Option Exercise16.6770,0001,166,900129,949Sep 29 05:16 PM
Williams Kristen MarieChief Administrative OfficerSep 17Option Exercise39.1927,8711,092,26852,758Sep 17 07:13 PM
REINHARDT MAXPresidentSep 17Option Exercise42.5425,0001,063,50039,000Sep 21 06:23 PM
REINHARDT MAXPresidentSep 17Sale59.8125,4201,520,31814,000Sep 21 06:23 PM
Williams Kristen MarieChief Administrative OfficerSep 17Sale59.8227,8711,667,29024,887Sep 17 07:13 PM
Riker Lauren BullaroVice President, FinanceSep 16Option Exercise10.813,00032,43016,181Sep 17 07:10 PM
Williams Kristen MarieChief Administrative OfficerSep 16Option Exercise39.1927,8531,091,56052,740Sep 17 07:13 PM
Williams Kristen MarieChief Administrative OfficerSep 16Sale60.1427,8531,675,15024,887Sep 17 07:13 PM
Riker Lauren BullaroVice President, FinanceSep 16Sale60.343,000181,02013,181Sep 17 07:10 PM
Williams Kristen MarieChief Administrative OfficerSep 15Option Exercise39.1927,8531,091,56052,740Sep 17 07:13 PM
Williams Kristen MarieChief Administrative OfficerSep 15Sale59.3927,8531,654,05824,887Sep 17 07:13 PM
Wicki AndreasDirectorSep 09Sale62.022,216137,436692,970Sep 11 08:03 PM
STACK DAVID MCEO and ChairmanAug 17Sale61.9115,000928,619173,377Aug 19 05:44 PM
Wicki AndreasDirectorAug 13Sale61.4734,9042,145,549695,186Aug 13 08:58 PM
Wicki AndreasDirectorAug 12Sale60.82113,5006,903,070730,090Aug 13 08:58 PM
Riker Lauren BullaroVice President, FinanceAug 11Option Exercise10.348,18084,58120,813Aug 13 04:35 PM
Wicki AndreasDirectorAug 11Sale61.32106,7726,546,747843,590Aug 13 08:58 PM
Riker Lauren BullaroVice President, FinanceAug 11Sale60.508,180494,89013,181Aug 13 04:35 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsAug 03Option Exercise44.102,500110,25022,750Aug 05 05:16 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsAug 03Sale52.682,500131,70020,796Aug 05 05:16 PM
STACK DAVID MCEO and ChairmanJul 15Sale56.8812,000682,560188,377Jul 17 05:44 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsJun 29Option Exercise42.0756,2502,366,58880,351Jul 01 09:17 PM
Riker Lauren BullaroVice President, FinanceJun 29Option Exercise10.346,00062,04018,633Jul 01 09:20 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsJun 29Sale50.2760,1013,021,31420,250Jul 01 09:17 PM
Riker Lauren BullaroVice President, FinanceJun 29Sale49.476,000296,80012,633Jul 01 09:20 PM
STACK DAVID MCEO and ChairmanJun 08Sale48.1217,111823,402166,909Jun 08 09:09 PM
Brege LauraDirectorJun 05Sale48.702,100102,2706,661Jun 08 09:04 PM
Riker Lauren BullaroVice President, FinanceJun 05Sale48.371,75284,7447,833Jun 08 09:08 PM
Williams Kristen MarieChief Administrative OfficerJun 05Sale48.615,904286,99310,887Jun 08 09:10 PM
Williams Kristen MarieChief Administrative OfficerJun 04Sale46.332,402111,28716,791Jun 08 09:10 PM
STACK DAVID MCEO and ChairmanJun 04Sale46.3314,314663,182184,020Jun 08 09:09 PM
Riker Lauren BullaroVice President, FinanceJun 04Sale46.3387940,7259,585Jun 08 09:08 PM
McLoughlin DennisChief Commercial OfficerJun 04Sale46.331,44767,04114,898Jun 08 09:07 PM
Reinhart Charles A. IIIChief Financial OfficerJun 04Sale46.331,48968,98714,847Jun 08 09:07 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsJun 04Sale46.3386339,98410,101Jun 08 09:06 PM
HASTINGS PAUL JDirectorJun 04Sale47.462,02596,1074,856Jun 08 09:05 PM
Riker Lauren BullaroVice President, FinanceMay 21Option Exercise10.342,00020,68012,464May 21 07:19 PM
Riker Lauren BullaroVice President, FinanceMay 21Sale45.262,00090,52010,464May 21 07:19 PM
Riker Lauren BullaroVice President, FinanceMay 19Option Exercise10.342,00020,68012,464May 21 07:19 PM
Riker Lauren BullaroVice President, FinanceMay 19Sale42.812,00085,62010,464May 21 07:19 PM
PACE GARY WDirectorMar 12Option Exercise4.4621,73696,84558,689Mar 16 05:54 PM
LONGENECKER JOHN P PHDDirectorMar 12Option Exercise1.613,7366,01516,497Mar 16 05:53 PM
WINSTON ROYChief Clinical OfficerMar 11Buy36.502,50091,25025,237Mar 12 07:18 PM
STACK DAVID MCEO and ChairmanFeb 21Option Exercise3.3835,856121,189198,334Feb 25 04:55 PM
Riker Lauren BullaroVice President, FinanceFeb 10Option Exercise10.813,00032,43013,464Feb 12 04:41 PM
Riker Lauren BullaroVice President, FinanceFeb 10Sale48.813,000146,43010,464Feb 12 04:41 PM
Riker Lauren BullaroVice President, FinanceFeb 07Option Exercise10.811701,83810,634Feb 10 06:19 PM
Riker Lauren BullaroVice President, FinanceFeb 07Sale46.811707,95810,464Feb 10 06:19 PM
Riker Lauren BullaroVice President, FinanceFeb 06Option Exercise10.818308,97211,294Feb 10 06:19 PM
Riker Lauren BullaroVice President, FinanceFeb 06Sale46.8183038,85210,464Feb 10 06:19 PM
STACK DAVID MCEO and ChairmanJan 15Option Exercise10.8125,000270,25026,208Jan 17 06:13 PM
STACK DAVID MCEO and ChairmanJan 15Sale42.6825,0001,066,9681,208Jan 17 06:13 PM
STACK DAVID MCEO and ChairmanDec 26Option Exercise3.5520,00071,000162,299Dec 30 04:05 PM
Riker Lauren BullaroVice President, FinanceDec 23Option Exercise10.811,00010,81011,464Dec 26 04:08 PM
Riker Lauren BullaroVice President, FinanceDec 23Sale45.921,00045,92010,464Dec 26 04:08 PM
McLoughlin DennisChief Commercial OfficerDec 16Sale45.793,671168,10816,116Dec 18 06:54 PM
LONGENECKER JOHN P PHDDirectorDec 02Option Exercise1.614,0006,44014,061Dec 04 04:46 PM
LONGENECKER JOHN P PHDDirectorDec 02Sale46.131,30059,97212,761Dec 04 04:46 PM